MOLECULAR AND CELLULAR BIOCHEMISTRY
Scope & Guideline
Elevating Knowledge in Biochemistry Since 1973
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
Investigates the biochemical pathways and molecular interactions that contribute to various diseases, including cancer, cardiovascular diseases, and metabolic disorders. - Cellular Signaling and Regulation:
Explores the cellular signaling pathways and regulatory mechanisms that influence cell behavior, including proliferation, apoptosis, and differentiation. - Biomarkers and Therapeutic Targets:
Focuses on the identification and validation of biomarkers for disease diagnosis, prognosis, and therapeutic targets, particularly in cancer and metabolic syndromes. - Stem Cell Biology and Regenerative Medicine:
Studies the role of stem cells in development and their potential therapeutic applications for tissue regeneration and repair. - Nutritional Biochemistry and Pharmacology:
Examines the impact of dietary components and pharmacological agents on cellular processes and their potential applications in disease prevention and treatment. - Emerging Technologies in Biochemistry:
Utilizes cutting-edge techniques such as CRISPR, single-cell sequencing, and metabolomics to advance understanding of biochemical processes.
Trending and Emerging
- Ferroptosis and Cell Death Mechanisms:
An increased interest in ferroptosis as a regulated form of cell death is evident, highlighting its implications in cancer, neurodegeneration, and organ injury. - MicroRNA and Non-Coding RNA Regulation:
The role of microRNAs and long non-coding RNAs in regulating gene expression and their involvement in various diseases, particularly cancer and metabolic disorders, is gaining momentum. - Metabolomics and Systems Biology:
A growing emphasis on metabolomics and systems biology approaches is seen, allowing for a comprehensive understanding of cellular metabolism and its implications in health and disease. - Immunometabolism and Inflammation:
Research focusing on the intersection of metabolism and immune response is trending, especially in the context of chronic diseases and COVID-19. - Targeted Therapies and Precision Medicine:
There is a noticeable increase in studies exploring targeted therapies and precision medicine approaches, particularly in oncology and chronic diseases. - Stem Cell-Derived Therapeutics:
Research on the therapeutic potential of stem cells and their derivatives, including exosomes, is emerging strongly, reflecting the interest in regenerative medicine.
Declining or Waning
- Classical Pharmacology Studies:
There has been a noticeable decrease in traditional pharmacological studies, likely due to the increasing shift towards personalized medicine and targeted therapies. - Basic Biochemical Pathways without Disease Context:
Research focusing solely on fundamental biochemical pathways without linking them to specific diseases or therapeutic implications is becoming less prominent. - Animal Models in Basic Research:
The reliance on animal models for basic biochemical research is declining as researchers increasingly seek alternative methods, such as organoids or in vitro models, to study disease mechanisms. - General Reviews without Novel Insights:
Reviews that do not provide new insights or advancements in the field are less frequently published, as the journal emphasizes innovative contributions.
Similar Journals
FASEB BioAdvances
Exploring Breakthroughs in Biological ResearchFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
Annual Review of Biochemistry
Elevating Research Standards in BiochemistryAnnual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.
Biochemistry Moscow Supplement Series A-Membrane and Cell Biology
Bridging Gaps in Biochemical UnderstandingBiochemistry Moscow Supplement Series A-Membrane and Cell Biology, published by PLEIADES PUBLISHING INC in the United States, is a pivotal journal in the fields of biochemistry, biophysics, and cell biology. Established in 2008, this journal has become a significant platform for disseminating novel research findings and reviews, fostering advanced studies in membrane dynamics and cellular processes. Although currently ranked in the Q4 quartile across its categories, the journal provides researchers and professionals with open access to a wealth of knowledge, helping to bridge gaps in understanding complex biochemical mechanisms. The journal’s commitment to quality and relevance is evident as it continues to contribute to the academic community through its coverage of innovative and emerging topics in cell and membrane biology. Researchers, practitioners, and students alike will find this resource invaluable for keeping abreast of the latest developments in the ever-evolving landscape of biochemistry and cellular research.
Cell Discovery
Showcasing Innovations that Transform Life SciencesCell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.
CURRENT MOLECULAR MEDICINE
Advancing the Frontiers of Molecular MedicineCURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.
BIOCHEMICAL JOURNAL
Fostering Innovation in Biochemistry and BeyondBIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.
CELL BIOCHEMISTRY AND BIOPHYSICS
Connecting Biochemistry, Biophysics, and Cell BiologyCELL BIOCHEMISTRY AND BIOPHYSICS is a distinguished journal published by HUMANA PRESS INC, focusing on critical advancements in the fields of biochemistry, biophysics, and cell biology. Since its establishment, the journal has provided a robust platform for the dissemination of cutting-edge research, covering diverse aspects of cellular biochemistry and the physical principles that underlie biological systems. With an emphasis on interdisciplinary studies, the journal aims to facilitate knowledge exchange among researchers, professionals, and students from various scientific backgrounds. As reflected in its 2023 category rankings, it holds a respectable position in Q3 for Biochemistry and Cell Biology, and Q2 for both Biophysics and Medicine (miscellaneous), indicating its significant contribution to these fields. Although it operates under a subscription model, the journal's commitment to maintaining high publication standards ensures that only impactful studies are shared with its audience. With a range of articles spanning theoretical insights to practical applications, CELL BIOCHEMISTRY AND BIOPHYSICS is an essential resource for those aiming to stay at the forefront of biochemical and biophysical research.
BIOCHEMICAL SOCIETY TRANSACTIONS
Advancing Biochemical Knowledge for a Brighter FutureBIOCHEMICAL SOCIETY TRANSACTIONS is a premier journal published by Portland Press Ltd, renowned for its rigorous dissemination of cutting-edge research in the field of biochemistry. Established in 1973 and currently spanning until 2024, this journal has solidified its standing with an impressive Q1 category ranking in Biochemistry, reflecting its commitment to high-quality scholarship and innovation. It plays a crucial role in bridging current biochemical research with its practical applications, making it an invaluable resource for researchers, professionals, and students alike. The journal enjoys a commendable position in the Scopus Ranks, sitting at Rank #105 out of 438 journals in its category, placing it in the 76th percentile among similar publications. While the journal maintains a subscription-only access policy, it promises to provide readers with comprehensive insights and discoveries that drive advancements in biochemistry and related fields. This journal is not just a repository of information; it is a vibrant community dedicated to the progress of biochemistry, making it essential reading for anyone involved in this dynamic discipline.
IUBMB LIFE
Connecting Researchers to the Future of Life SciencesIUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.
Cell Communication and Signaling
Connecting Scientists Through Open Access DiscoveriesCell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.